Zhen-Ao Group is a large-scale high-tech group in health industry engaged mainly in developing nucleic acid products with contemporary biological technology and integrating R & D, production and sales of natural medicines, biological products, health-care foods, cosmetics and health-care textiles, etc.
In 1996, Dalian Zhen-Ao Nucleic Acid Science & Technology Development Co., Ltd. was established, which was restructured into Dalian Zhen-Ao Bio-engineering Stock Co., Ltd. in Oct. 2000. In 2003, Zhen-Ao Group was registered as the largest nucleic acid industrialization base in China and a key high-tech enterprise in national Torch Plan. Now the total registered capital of Zhen-Ao Group has amounted to RMB 181.07 million. Zhen-Ao Group, as a parent company, consists of such five sub-companies as Dalian Zhen-Ao Pharmaceutical Co., Ltd., Fujian Zhen-Ao Nucleic Acid Co., Ltd., Shanghai Zhen-Ao HTB Biological Science & Technology Co., Ltd., Dalian Zhen-Ao Import & Export Co., Ltd. and Dalian Shuangdi Biological Science & Technology Company.
Headquartered in Zhen-Ao Life Garden, DD Port, Dalian High-tech Park, Zhen-Ao Group covers land area of 380,000 m2 in which a scientific research center, a research institute and a provincial bioengineering research center are established. It has a scientific research building over 2,000 m2 equipped with fine domestic and foreign advanced scientific research equipment and testing instruments. There are three mid-trial bases in Dalian, Shanghai and Fuzhou with nearly one hundred workers engaged directly in R & D.
Zhen-Ao Group always insists on the stratagem of technological research starting at high level and crossing over at rapid speed. With the tenet of ¡°Base self upon life science to benefit human being¡¯s health¡±, it develops, manufactures and sells health foods, restoratives, biochemicals, Chinese traditional medicines, cosmetics and other health products by the way to adopt modern biotechnology combining with Chinese traditional medical science with natural active materials, natural medicine as main developing target. It has acquired successively ISO9001 attestation, GMP attestation for medicines, GMP attestation for health-care foods, HACCP food safety prevention and control system attestation and ISO14001 environmental standard attestation. Internationally it has acquired FDA business registration and product customs inspection in USA and the health product accession attestation issued by Ministry of Health and Welfare Japan.
Zhen-Ao Group owns nearly 500 varieties of multi-functional, multi-series products, consisting of multiple medicines with Cardiomyopeptide for Injection, the new medicine of national category I with private intellectual property rights as the core product; multiple series of health-care products and nutritional foods with Zhen-Ao nucleic acid as the core; multiple condiments of nucleotide series; series of cosmetics, daily chemical product with nucleotide as the main ingredient; Zhen-Ao HTB series of textiles with health-care functions; home health-care appliances, etc. Zhen-Ao Nucleic Acid capsule, Zhen-Ao Gantai (for hepatic) capsule, and Zhen-Ao Zhishuping (for blood fat) capsule are the first health-care products by clinical testing in China, which have been always popular with domestic and foreign consumers with their reliable functions and exported to many countries and regions, including USA, Canada, Japan, South Korea, and Southeast Asia, etc.
The Group owns 35 marketing management organizations at provincial level, 245 marketing organizations at prefecture and city levels and over 3,000 terminal stores for sales service with over 50,000 employees. Over 4 million consumers have become stably and people benefiting directly has exceeded ten million.
In addition, Zhen-Ao Group has also repaid and dedicated itself to the society by shouldering the responsibility of an enterprise to construct a harmonious society. Over the past ten years, it has invested RMB 260 million yuan in fields like social public welfare and charity. Chairman of Board Chen Yusong won the national top ten ¡°Love Donation Prize¡± and the title ¡°China 100 Most Influential Charity Individuals¡± issued by China Ministry of Civil Affairs.
In 2003, the group ranked in the fourth place among the top ten key enterprises in China¡¯s industry with best benefits as published by National Statistic Bureau and in the eighth place among private-owned enterprise taxpayers in Liaoning Province; From 2002 to 2004, the Group was put in the list of 50 major taxpayers in Dalian; from 2003 to 2004, the Group was appraised by Dalian Municipal Administration of Taxation as an AAA-credit taxpaying enterprise; From 2002 to 2005, the Group won consecutively the national ¡°Top Ten Health-care Products¡± and ¡°Top Ten Enterprises¡±; in 2005, it won the title of the independent brand with the best potential for growth in the industry and was selected as vice chairman unit of China Enterprise Citizen Working Commission; in the same year, ¡°Zhen-Ao¡± won the title of famous trademark, famous brand for export in China.
Zhen-Ao Group has showed an optimistic prospect for tomorrow with its firm foundation work and vast development space. It will definitely achieve more development and more success in the great cause to devote itself to the health industry to benefit the health of human beings and to build a harmonious society.
